Clinical Trial Update: Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating glucocorticoids versus placebo for acute exacerbation of idiopathic pulmonary fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exacerbation of Idiopathic Pulmonary Fibrosis
• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• glucocorticoids (glucocorticoids)

Snippet

Sponsor: Fondation Hôpital Saint-Joseph | Conditions: Acute Exacerbation of Idiopathic Pulmonary Fibrosis | Phase 3 | Status: RECRUITING